14 results match your criteria: "Private Clinic "Vita-Center"[Affiliation]"

Article Synopsis
  • The study focused on the relationship between microvesicles from dying endothelial cells and different types of chronic heart failure (HF).
  • The research involved 388 HF patients, including those with reduced, preserved, and mid-range left ventricular ejection fractions.
  • Key findings indicated that while some microvesicle markers were similar in certain HF patients, specific markers, especially CD144/annexin V MVs, were significantly higher in HFrEF patients and could enhance prediction capabilities for heart failure outcomes.
View Article and Find Full Text PDF

Are inflammatory cytokines and angiogenic factors a predictive biomarker of diabetes retinopathy?

Diabetes Metab Syndr

December 2017

Private Clinic "Vita-Center", 3, Sedova str., Zaporozhye, Ukraine; Internal Medicine Department, State Medical University of Zaporozhye, 26, Mayakovsky av., Zaporozhye, Ukraine. Electronic address:

View Article and Find Full Text PDF

Cardiac biomarkers in diabetes mellitus: New dawn for risk stratification?

Diabetes Metab Syndr

November 2017

Private Hospital "Vita-Center", Zaporozhye, Ukraine; Internal Medicine Department, Medical University of Zaporozhye, Ukraine. Electronic address:

Type 2 diabetes mellitus (T2DM) remains a leading cause of cardiovascular (CV) events and diseases worldwide. The aim of the review is to summarize our knowledge regarding clinical implementation of the biomarker-based strategy of the CV risk assessment in T2DM patient population. There is large body of evidence regarding use of the cardiac biomarkers to risk stratification at higher CV risk individuals who belongs to general population and cohort with established CV disease.

View Article and Find Full Text PDF

Background: The decreased number and impaired functions of endothelial progenitor cells (EPCs) may associate with cardiovascular disease (CV) including atherosclerosis. However, the role of vistafin in regulation of angiogenic EPC subset maturation in T2DM patients without known atherosclerosis is still not fully understood.

The Aim Of The Study: To investigate an association of serum vistafin level and number of circulating EPCs in T2DM patients beyond known CV disease.

View Article and Find Full Text PDF

Metabolic syndrome (MetS) is defined as cluster of multiple metabolic and cardiovascular (CV) abnormalities included abdominal obesity, high-normal blood pressure, dyslipidaemia, and impaired fasting glucose tolerance that exhibits has a growing prevalence worldwide. We investigated whether an elevated level of osteoprotegerin (OPG) predicts imbalance between different phenotypes of circulating endothelial (EPCs) and mononuclear (MPCs) progenitor cells in MetS patients. We have analyzed data regarding dysmetabolic disorder subjects without known CV disease), as well as with known type two diabetes mellitus.

View Article and Find Full Text PDF
Article Synopsis
  • The study focused on the patterns of circulating microparticles (MPs) in type 2 diabetes patients who have asymptomatic atherosclerosis.
  • A total of 103 T2DM patients and 35 healthy volunteers were analyzed to compare the levels and types of MPs, revealing that T2DM patients had specific MP variations linked to atherosclerosis.
  • Key findings indicated that certain factors like BMI, LDL cholesterol, and specific types of MPs were independent predictors of asymptomatic atherosclerosis in T2DM patients.
View Article and Find Full Text PDF

Background: Chronic heart failure (HF) remains a leading cause of cardiovascular (CV) mortality and morbidity worldwide. The aim of the study was to investigate whether the pattern of angiogenic endothelial progenitor cells (EPCs) and apoptotic endothelial cell-derived microparticles (EMPs) would be able to differentiate HF with reduced (HFrEF) and preserved (HFpEF) ejection fraction.

Methods: One hundred sixty four chronic HF subjects met inclusion criteria.

View Article and Find Full Text PDF

The utility of biomarker risk prediction score in patients with chronic heart failure.

Int J Clin Exp Med

January 2016

2nd Department of Internal Medicine, St. Anne's University Hospital and Masaryk UniversityBrno, Czech Republic; Laboratory of Structural Biology and Proteomics, Faculty of Pharmacy, University of Veterinary and Pharmaceutical SciencesBrno, Czech Republic.

Article Synopsis
  • Chronic heart failure (CHF) is a major cause of cardiovascular-related deaths, and current risk models need to be improved; this study investigates if a biomarker risk prediction score can enhance three-year risk assessments for cardiovascular outcomes in CHF patients.
  • The study followed 388 CHF patients over an average of 2.76 years, recording 285 cardiovascular events (43 deaths, 242 readmissions) while measuring various biomarkers such as NT-pro-BNP, galectin-3, and hs-CRP.
  • The results indicate that specific biomarkers are independent predictors of clinical outcomes and that a calculated cardiovascular risk index could help differentiate patient survival prospects based on their risk scores.
View Article and Find Full Text PDF
Article Synopsis
  • The study aimed to determine if circulating microparticles linked to cell death can help predict cardiovascular risks in patients with congestive heart failure (CHF) over three years.
  • During a follow-up of 2.32 years involving 388 patients, 110 cardiovascular events, including 43 deaths, were recorded, highlighting the serious nature of CHF.
  • Key factors linked to these outcomes included certain biomarkers (like NT-pro-BNP and hs-CRP) and specific types of apoptotic microparticles, suggesting that analyzing these could enhance risk assessment for patients with CHF.
View Article and Find Full Text PDF

Background: Subclinical hypothyroidism (SH) is diagnosed biochemically by the presence of normal serum free thyroxine concentration, in conjunction with an elevated serum thyroid-stimulating hormone level. Recent studies have demonstrated the frequent association between SH and cardiovascular diseases and risk factors.

Objectives: To evaluate the impact of SH on patterns of circulating endothelial-derived microparticles, (EMPs) among chronic heart failure (CHF) patients.

View Article and Find Full Text PDF

Unlabelled: The study aim was to evaluate the impact of dysmetabolic comorbidities including subclinical hypothyroidism (SH) on pattern of circulating endothelial-derived microparticles (EMPs) in chronic heart failure (CHF) patients.

Methods: It was retrospectively involved a cohort of 388 patients with CHF. Fifty three CHF subjects had SH and 335 patients were free from thyroid dysfunction.

View Article and Find Full Text PDF

Background: Chronic heart failure (CHF) has been remained a leading cause of cardiovascular morbidity and mortaluty. The risk stratification of CHF individuals based on clinical criteria and biomarkers' models may improve medical care and probably increase efficacy of treatment strategy. However, various predictive models approved for CHF patients appear to be distinguished in their prognostications.

View Article and Find Full Text PDF